FDA Orange Book
Is there a generic for MultiHance?
MultiHance contains gadobenate dimeglumine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for MultiHance (gadobenate dimeglumine).
Run it in Rivvi
Map MultiHance and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
MultiHance products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, intravenous | 10.58GM/20ML (529MG/ML) | Marketed (Rx) | None | 0 | None |
| injectable, intravenous | 2.645GM/5ML (529MG/ML) | Marketed (Rx) | None | 0 | None |
| injectable, intravenous | 5.29GM/10ML (529MG/ML) | Marketed (Rx) | None | 0 | None |
| injectable, intravenous | 7.935GM/15ML (529MG/ML) | Marketed (Rx) | None | 0 | None |
NDA 021357, held by BRACCO DIAGNOSTICS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
MultiHance NDC codes
Questions
Is there a generic for MultiHance?
No. The Orange Book lists no active FDA-approved generic (ANDA) for MultiHance (gadobenate dimeglumine).
What is the generic name for MultiHance?
The active ingredient in MultiHance is gadobenate dimeglumine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.